Real-time enrollment status for this meningioma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:13 PM UTC
| NCT Number | NCT05940493 |
| Recruiting Status | Recruiting |
| Condition | Meningioma |
| Phase | PHASE2 |
| Target Enrollment | 72 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Nader Sanai |
| Last Updated on CT.gov | March 13, 2026 (Mar 13, 2026) |
As of July 17, 2026: Clinical trial NCT05940493 is currently recruiting participants. This phase2 study for meningioma is actively seeking new participants at 1 location across the United States. The study is sponsored by Nader Sanai. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05940493 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05940493 was last updated Mar 13, 2026 (March 13, 2026). HelloStudys verifies this status automatically.